Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

LSZ 102

Next Previous
X
Search
Drug Profile

LSZ 102

Alternative Names: LSZ-102

Latest Information Update: 01 Nov 2021

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Novartis
  • Class Antineoplastics
  • Mechanism of Action Selective estrogen receptor degraders
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Breast cancer

Most Recent Events

  • 01 Nov 2021 Discontinued - Phase-I for Breast cancer (Combination therapy, Late-stage disease, Metastatic disease, Monotherapy, Second-line therapy or greater) in France, Italy, Japan, Singapore, Germany, USA, Belgium (PO) (Novartis pipeline, November 2021)
  • 11 Oct 2021 Novartis terminates a phase-I/Ib clinical trial in Breast cancer (Combination therapy, Late-stage disease, Metastatic disease, Second-line therapy or greater) in USA, Belgium, France, Germany, Italy, Japan and Singapore (PO) (NCT02734615)
  • 29 Apr 2020 Phase-I development is ongoing for Breast-cancer(Combination therapy, Late-stage disease, Metastatic disease, Monotherapy, Second-line therapy or greater) in Italy, France, Singapore, Japan, Belgium and in USA (PO) (NCT02734615)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top